International Biotechnology Trust plc reported earnings results for the full year ended August 31, 2023. For the full year, the company reported net income was GBP 6.81 million compared to net loss of GBP 22.47 million a year ago. Basic earnings per share from continuing operations was GBP 0.1679 compared to basic loss per share from continuing operations of GBP 0.5472 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
702 GBX | +0.29% |
|
+9.35% | +9.35% |
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.35% | 338M | |
+10.99% | 15.43B | |
+6.86% | 6.69B | |
+32.18% | 5.31B | |
+10.43% | 4.49B | |
-8.05% | 4.13B | |
+14.31% | 3.65B | |
+0.96% | 3.57B | |
+12.05% | 3.24B | |
+18.53% | 3.04B |
- Stock Market
- Equities
- IBT Stock
- News International Biotechnology Trust plc
- International Biotechnology Trust plc Reports Earnings Results for the Full Year Ended August 31, 2023